IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
IB Acquisition operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
IB Acquisition's operating cash flow for the twelve months ending Jun 30, 2026 was -$1.85M. For fiscal 2025 it was -$1.32M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$1.32M | – |
| FY2024 | Sep 30, 2024 | -$820.96K | – |
| FY2023 | Sep 30, 2023 | -$207 | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Jun 30, 2026 | -$474.47K | – |
| Q2 FY2026 | Mar 31, 2026 | -$265.85K | – |
| Q1 FY2026 | Dec 31, 2025 | -$1.05M | – |
| Q4 FY2025 | Sep 30, 2025 | -$57.32K | – |
| Q3 FY2025 | Jun 30, 2025 | -$141.36K | – |
| Q2 FY2025 | Mar 31, 2025 | -$744.19K | – |
| Q1 FY2025 | Dec 31, 2024 | -$375.24K | – |
| Q4 FY2024 | Sep 30, 2024 | -$53.85K | – |
| Q3 FY2024 | Jun 30, 2024 | -$585.24K | – |
| Q2 FY2024 | Mar 31, 2024 | -$103.83K | – |
| Q1 FY2024 | Dec 31, 2023 | -$78.04K | – |
| Q4 FY2023 | Sep 30, 2023 | -$63 | – |
| Q3 FY2023 | Jun 30, 2023 | -$48 | – |